Effect of Kangaroo Mother Care on Oxidative Stress and Bonding
KMC
Impact of Kangaroo Mother Care on Selected Bio Marker and Maternal-Infant Bonding in Preterm Neonates in a Tertiary Care Hospital of Lahore, Pakistan
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to learn if Kangaroo Mother care can have effect on oxidative stress in premature neonates. It will also learn about the bonding between mother and her premature infant. The main questions it aims to answer are:
- Does Kangaroo mother care lower the biomarker of oxidative stress in premature neonates?
- Is Kangaroo mother care associated with mother-infant bonding? Researchers will compare Kangaroo mother care to Conventional incubator care to see if Kangaroo mother care works to have effect on oxidative stress. Participants will be:
- given Kangaroo mother care on third day of life or standard incubator care for one hour
- Urine sample for oxidative stress biomarker will be collected via noninvasive method before and after Kangaroo mother care or conventional incubator care from premature neonates.
- Mother-infant bonding scale will be filled by mothers of enrolled premature infants before and after kangaroo mother care and conventional incubator care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2024
CompletedFirst Submitted
Initial submission to the registry
March 22, 2024
CompletedFirst Posted
Study publicly available on registry
March 29, 2024
CompletedApril 1, 2024
March 1, 2024
8 months
March 22, 2024
March 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
biomarker of Oxidative Stress (Allantoin) in urine sample of premature infants
Biomarker of oxidative stress (Allantoin) in urine samples of premature infants by ELISA Testing before and after one hour session of KMC by ELIZA testing
OnThird day of life before and after one hour of KMC or Conventional care
Mother- Infant Bonding
by Using Mother Infant bonding self rating scale (MIBS) of eight points descriptors bonding between mother and her infant will be measured. Total scores range from 0 to 24. A high score indicates worst mother to infant bonding.
OnThird day of life before and after one hour of KMC or Conventional care
Study Arms (2)
KMC group
EXPERIMENTALPremature infants and their mothers who will be provided with kangaroo mother care on third day of life. baby will be placed on bare chest of mother and before and after KMC urine samples will be collected from premature infants.
Control group
NO INTERVENTIONpremature infants and their mothers who will be provided with same conventional incubator care in NICU on day third of life their urine samples will also be collected before and after conventional care
Interventions
KMC is a care system for LBW and preterm infants at birth, based on skin-to-skin contact between the infant and the mother and exclusive breast feeding. The mother carries her Preterm infant for at least one hour per day. Urine collected before and after skin-to-skin contact.
Eligibility Criteria
You may qualify if:
- For Pre-term Neonates:
- weeks' gestation Premature infants
- Medically stable as determined by a Score of Neonatal Acute Physiology \& Perinatal Extension (SNAPPE-II); pre-term neonates with score of less than 9.
- Both gender
- Weight 1.5kg to 2.499 kg
- For Mothers of Pre-term Neonates:
- \. Medically stable Mothers.
You may not qualify if:
- For Pre-term Neonates:
- Those will be excluded who are with below given conditions:
- Require any kind of surgery.
- Intraventricular hemorrhage (IVH) \> or equal to grade 3.
- On medication such as morphine, fentanyl, midazolam, muscle relaxants, phenobarbital.
- Severe cyanotic heart disease or severe RDS.
- Abdominal wall or intestinal anomaly or injury.
- Chromosomal Disorder
- Facial anomaly.
- For Mothers of Pre-term Neonates:
- Mothers having Complications of delivery like Post partem hemorrhage.
- Any acute illness
- Complicated cesarean section
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Health Sciences Lahorelead
- Services Hospital, Lahorecollaborator
Study Sites (1)
Services Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samreen Manzoor, MSN
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 22, 2024
First Posted
March 29, 2024
Study Start
August 1, 2023
Primary Completion
March 20, 2024
Study Completion
March 20, 2024
Last Updated
April 1, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After publication data will be available and available till infinite time
- Access Criteria
- criteria will be uploaded after the publication of this research
Data that will be published in research article. Data will be available to other researchers. data of all participants after analysis will be included in research article.